Apathy and APOE in mild behavioral impairment, and risk for incident dementia

Daniella Vellone1, Maryam Ghahremani1,2, Zahra Goodarzi1,3,4,5,6

  • 1Hotchkiss Brain Institute Cumming School of Medicine University of Calgary Calgary Alberta Canada.

Abstract

Insights

Mild behavioral impairment with apathy significantly increases dementia risk, particularly in individuals with normal cognition. Apolipoprotein E genotype also influences this risk, highlighting potential targets for intervention.

Area of Science:

  • Neuroscience
  • Gerontology
  • Psychiatry

Background:

  • Mild behavioral impairment (MBI) is a high-risk state for dementia.
  • Apathy is a common symptom in dementia and can also occur in normal cognition (NC) or mild cognitive impairment (MCI).
  • Persistent apathy within MBI may drive dementia risk.

Purpose of the Study:

  • To investigate the association between MBI-apathy and progression to dementia.
  • To examine effect modification by sex, race, cognitive diagnosis, and apolipoprotein E (APOE) genotype.

Main Methods:

  • Stratified dementia-free participants by persistent apathy status using Neuropsychiatric Inventory (NPI) scores.
  • Used Cox proportional hazards regressions to determine hazard ratios (HRs) for incident dementia.
  • Adjusted for baseline demographics, cognitive diagnosis, and APOE genotype; explored interaction effects.

Main Results:

  • MBI-apathy showed the highest dementia incidence (HR = 2.69).
  • Apathy's contribution to dementia risk was greater in NC (HR = 5.91) than MCI (HR = 2.16).
  • Risk was greatest in APOE ɛ3 genotype (HR = 4.25).

Conclusions:

  • MBI-apathy markedly elevates dementia risk, especially in individuals with normal cognition.
  • Cognitive status and APOE genotype are key moderators of this relationship.
  • MBI-apathy may indicate preclinical/prodromal dementia, offering a target for precision interventions.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
608
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
153
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
240
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
661